approved glp 1 agonists GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More Comparing GLP-type therapies for weight
Description
Obesity While at the most basic level, obesity is caused by a person taking in more energy than they expend over a prolonged period, it is worth noting that humans have a complex neural mechanism regulating food intake, which is generally very effective at maintaining a balance between energy intake and expenditure
Novo Nordisk, for instance, markets two versions: Ozempic for diabetes, and Wegovy for weight loss
Available from: _Product_Information/human/002735/WC500165117.pdf
doi: 10.1210/en.2004-0495
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025
A., Yang, F
